Antibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 22788-1-AP - Provider product page

- Provider
- Proteintech Group
- Product name
- HIC2 antibody
- Antibody type
- Polyclonal
- Description
- HIC2 antibody (Cat. #22788-1-AP) is a rabbit polyclonal antibody that shows reactivity with human and has been validated for the following applications: IP, WB,ELISA.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Direct and indirect regulation of fetal globin transcript by RNA-binding protein IGF2BP1.
HIC2 suppresses glioblastoma progression via transcriptional repression of SEMA3A and inhibition of TGF-β signaling.
let-7 miRNAs repress HIC2 to regulate BCL11A transcription and hemoglobin switching.
Small extracellular vesicle-associated miR-6068 promotes aggressive phenotypes of prostate cancer through miR-6068/HIC2/SIRT1 axis.
HIC2 controls developmental hemoglobin switching by repressing BCL11A transcription.
Coyne S, Wu T, Hossain M, Vinjamur D, Starrs M, Zeng J, Andresen F, Gutierrez A, Shimamura A, Bauer DE
bioRxiv : the preprint server for biology 2025 Sep 9;
bioRxiv : the preprint server for biology 2025 Sep 9;
HIC2 suppresses glioblastoma progression via transcriptional repression of SEMA3A and inhibition of TGF-β signaling.
Zhang L, Yang J, Ke X, Huang N, Zhou D, Cai H
Free radical biology & medicine 2025 Dec 1;240:674-684
Free radical biology & medicine 2025 Dec 1;240:674-684
let-7 miRNAs repress HIC2 to regulate BCL11A transcription and hemoglobin switching.
Huang P, Peslak SA, Shehu V, Keller CA, Giardine B, Shi J, Hardison RC, Blobel GA, Khandros E
Blood 2024 May 9;143(19):1980-1991
Blood 2024 May 9;143(19):1980-1991
Small extracellular vesicle-associated miR-6068 promotes aggressive phenotypes of prostate cancer through miR-6068/HIC2/SIRT1 axis.
Gaballah MSA, Ali HEA, Hassan ZA, Mahgoub S, Ali HI, Rhim JS, Zerfaoui M, El Sayed KA, Stephen D, Sylvester PW, Abd Elmageed ZY
American journal of cancer research 2022;12(8):4015-4027
American journal of cancer research 2022;12(8):4015-4027
HIC2 controls developmental hemoglobin switching by repressing BCL11A transcription.
Huang P, Peslak SA, Ren R, Khandros E, Qin K, Keller CA, Giardine B, Bell HW, Lan X, Sharma M, Horton JR, Abdulmalik O, Chou ST, Shi J, Crossley M, Hardison RC, Cheng X, Blobel GA
Nature genetics 2022 Sep;54(9):1417-1426
Nature genetics 2022 Sep;54(9):1417-1426
No comments: Submit comment
No validations: Submit validation data